DRL-Header DRL-Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter
×
FILTER:
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type

            Companies

            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

            Lead Product(s): VHH72-Fc antibody

            Therapeutic Area: Infections and Infectious Diseases Product Name: XVR011

            Highest Development Status: IND Enabling Product Type: Large molecule

            Partner/Sponsor/Collaborator: VIB

            Deal Size: $50.0 million Upfront Cash: Undisclosed

            Deal Type: Series A Financing March 16, 2021

            Details:

            Unique llama-derived VHH72-Fc antibody (XVR011) for potential treatment and prevention of Covid-19, ready to start first-in-human trials.